11/20/2026 | Press release | Distributed by Public on 11/20/2026 09:09
|
FORM 4
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
|||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) | ||
|
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) |
4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Nonqualified Stock Option (right to buy) | $0.2664(1) | 11/19/2026 | A | 575,000(2) | (3) | 11/19/2036 | Common Stock | 575,000(2) | $ 0 | 575,000 | D | ||||
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
|
Kalkofen Donald A. 12708 FLORA MANOR DRIVE LA MARQUE, TX 77568 |
Chief Financial Officer | |||
| /s/ Donald A. Kalkofen | 11/20/2026 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | The exercise price equals the fair market value of a share of common stock on the date of grant, determined under the Issuer's 2026 Omnibus Equity Incentive Plan as the average of the closing bid and asked prices on the OTCQB market for the last preceding date on which there was a sale, which was November 18, 2026. |
| (2) | Share amounts are stated before any reverse stock split. The number of shares subject to the option and the exercise price are subject to proportionate adjustment under the Plan for any reverse stock split or other change in capitalization. |
| (3) | The option was granted under the Issuer's 2026 Omnibus Equity Incentive Plan pursuant to the Reporting Person's Amended and Restated Acting Chief Financial Officer Services Agreement dated May 21, 2026. As to 425,000 shares, the option vests in twelve equal monthly installments on each monthly anniversary of May 18, 2026, with installments whose vesting dates preceded the grant date vested on the grant date; as to 150,000 shares, the option vests in full upon an Uplisting Event as defined in that agreement. The option may not be exercised until a registration statement on Form S-8 covering the underlying shares has become effective. The grant was approved by the Issuer's Board of Directors and is exempt under Rule 16b-3(d). |